Iran is considered as one of the malaria-endemic countries in the globe. It is estimated that approximately 80％ of malaria infections happen only in two provinces, Sistan-Baluchestan and Hormozgan provinces (in southeast and south of Iran, respectively) [1]. Based on formal reports, Iran is in the pre-elimination phase of the infection and elimination of malaria is the final goal, which is targeted by 2020[2]. The total positive clinical cases dropped from 15378 to 960 between 2002 and 2017 in the country[1]. There are seven anopheline species as primary or secondary vectors of malaria in Iran including, Anophele (An.) culicifacies Giles (s.l.), An. dthali Patton, An. fluviatilis James (s.l.), An. maculipennis Meigen (s.l.), An. sacharovi Favre, An. stephensi Liston and An. superpictus Grassi (s.l.). These suitable vectors exist in several provinces[3].